European Patent Office issues patent for TPX™

Nclear Inc. is pleased to report the European Patent Office (EPO) has issued their Decision to Grant a European patent for Nclear’s engineered nanocrystal compound, TPX™. The mention of the grant was published on April 22, 2020 under European Patent No. 2890645 (see complete listing under the following link:  EP2890645).  This decision will protect our technology in key European countries, including United Kingdom, Germany, France, the Netherlands and Sweden.

Share:

Share on facebook
Share on twitter
Share on linkedin

More Posts

CONTACT
NCLEAR